“Evaluating Fluoxetine’s Growth-Inhibitory Impact on Clinical Isolates of Enteric Bacteria: Harnessing Repurposing Potential”. Microbiological & Immunological Communications 2, no. 2 (December 30, 2023): 89–96. Accessed May 6, 2026. https://rootspress.org/journals/index.php/MIC/article/view/454.